Medicrea is involved in the design and manufacture of new generation spinal implants for the treatment of all spinal column pathologies.
Company sold in 2020.
Investor(s):
Jean-Luc Rivière
Jean-Luc Rivière
Participation: minoritaire
Activities:
Spinal orthopedic implants
Leaders:
Denys Sournac
IXO intervention: 1,4 M€
Sales figures: 32,7 M€ (2019)
Effective: 184 (2019)